-
DE
Die Knochenabbaurate beschreibt, wie schnell Knochensubstanz abgebaut wird. Sie ist ein wichtiger Marker für Knochengesundheit und Osteoporoserisiko.
Add as Preferred SourceThe bone resorption rate measures how quickly bone tissue is broken down. It is a key marker for bone health and osteoporosis risk assessment.
The bone resorption rate describes the speed at which bone tissue is broken down in the body. Bone is not a static material but a living tissue that undergoes constant remodelling. Specialised cells called osteoclasts continuously break down old or damaged bone, while osteoblasts build new bone in its place. The bone resorption rate reflects how actively this breakdown process is occurring at any given time.
Under normal conditions, bone resorption and bone formation are in balance. When the bone resorption rate persistently exceeds the rate of new bone formation, bone density decreases over time. This imbalance raises the risk of conditions such as osteopenia and osteoporosis, as well as an increased susceptibility to fractures.
Several factors can contribute to an accelerated bone resorption rate:
The bone resorption rate can be assessed through several diagnostic approaches:
When bone tissue is broken down, specific breakdown products are released into the bloodstream or excreted in urine. The most commonly used bone resorption markers include:
Dual-energy X-ray absorptiometry (DXA) measures bone mineral density and provides indirect information about cumulative bone loss over time. It is the standard method for diagnosing osteoporosis and monitoring treatment response.
An elevated bone resorption rate often goes unnoticed for years because bone loss does not typically cause immediate pain. Early clinical signs may include:
In clinical practice, the bone resorption rate is used to estimate individual fracture risk, monitor the course of osteoporosis therapy and evaluate how well a patient is responding to treatment.
A balanced diet providing adequate calcium, vitamin D, vitamin K2, magnesium and protein forms the foundation of bone health. Calcium is the primary structural component of bone, vitamin D enhances its absorption from the gut, vitamin K2 directs calcium into bone tissue, and magnesium supports vitamin D activation. For individuals who want to support their nutrient intake for bone health, our bone complex supplement for targeted micronutrient support may be a useful addition to a balanced diet.
Weight-bearing and resistance exercises stimulate osteoblast activity and can help counteract elevated bone resorption. Regular physical activity is one of the most effective non-pharmacological strategies for maintaining bone density. Activities such as walking, jogging, dancing and strength training are particularly beneficial.
When the bone resorption rate is clinically elevated, several medications are available to slow bone loss. These include bisphosphonates, denosumab and selective oestrogen receptor modulators (SERMs). These agents work primarily by reducing osteoclast activity. Pharmacological treatment should always be supervised by a physician.
When dietary intake of bone-relevant nutrients is insufficient, targeted supplementation may help bridge the gap. Our Knochen-Komplex nutritional supplement combines key micronutrients that may contribute to maintaining a healthy bone structure. Supplementation should complement a varied diet and, where relevant, be discussed with a healthcare professional. Those looking for comprehensive micronutrient support for their bones can find further details on our bone health supplement product page.
Smoking and excessive alcohol consumption are both associated with increased bone resorption. Avoiding these risk factors, maintaining a healthy body weight and ensuring adequate sun exposure to support vitamin D synthesis are all practical steps to help keep the bone resorption rate in a healthy range.
An elevated bone resorption rate means that osteoclasts are breaking down bone tissue faster than osteoblasts can rebuild it. Over time, this imbalance leads to a reduction in bone density and increases the risk of osteoporosis and fractures. It is often detected through blood or urine tests measuring specific bone turnover markers.
The bone resorption rate is typically assessed using blood or urine tests that detect bone resorption markers such as CTX-I or NTX. These markers are produced during collagen breakdown in bone and reflect current osteoclast activity. DXA bone density scans provide complementary information about long-term bone loss.
Calcium, vitamin D, vitamin K2 and magnesium are considered the core nutrients for bone health. Calcium provides structural material, vitamin D promotes calcium absorption, vitamin K2 directs calcium into bone, and magnesium supports vitamin D metabolism. Adequate protein intake also plays an important supporting role in maintaining bone mass.
Peak bone mass is reached between the ages of 25 and 30. After this point, a gradual decline begins. In women, bone loss accelerates significantly after menopause due to falling oestrogen levels. Men are also affected, but typically at a later age and at a slower rate than women.
Yes. Weight-bearing and resistance exercises stimulate bone-forming osteoblasts and can help counterbalance elevated resorption. Activities such as walking, running, dancing and strength training are particularly effective. Regular physical activity is one of the most evidence-supported, non-pharmacological approaches to maintaining bone health.
Not necessarily. Mildly elevated levels can occur within normal physiological variation, for example during growth phases or after injuries. Treatment becomes relevant when the elevation is persistent, associated with reduced bone density or accompanied by a clinically meaningful increase in fracture risk. A physician should always evaluate the individual situation.